Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine.
Mathieson
P W
PW
Department of Medicine, University of Cambridge, Cambridge, UK.
Peat
D S
DS
Short
A
A
Watts
R A
RA
D019268:Antibodies, Antineutrophil Cytoplasmic; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001323:Autoantibodies / Q000378:metabolism; D001327:Autoimmune Diseases / Q000209:etiology; D005921:Glomerulonephritis / Q000150:complications / Q000209:etiology* / Q000473:pathology; D015433:Glomerulonephritis, Membranous / Q000150:complications / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000009:adverse effects*; D011507:Proteinuria / Q000209:etiology; D014657:Vasculitis / Q000209:etiology
D019268:Antibodies, Antineutrophil Cytoplasmic; D018501:Antirheumatic Agents; D001323:Autoantibodies; D010396:Penicillamine